Trial NCT00427973

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2009-00130
Secondary IDs: 05-311 CDR0000526405 N02CO12400

Last trial update was posted on 2016-10-31

MeSH Interventions

Cediranib

MeSH Conditions

Carcinoma Carcinoma, Hepatocellular Liver Neoplasms

Other Conditions

Adult Primary Hepatocellular Carcinoma Advanced Adult Primary Liver Cancer Localized Unresectable Adult Primary Liver Cancer Recurrent Adult Primary Liver Cancer

Stopping Reasons

The study was stopped prior to 2nd stage.

Limitations And Caveats

Despite reaching the prespecified goal for the first stage of the trial, the study was stopped and did not proceed to the second stage after reviewing the development program of cediranib by AstraZeneca for reasons unrelated to this study.

Result Publications


Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID